Clinical trial · Observational
Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies: Helico-MQ Interventional Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Neoplasms | Gastric Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Helicobacter Pylori | — | UNRESOLVED | — |
| Stomach Neoplasms | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Helicobacter Pylori detection | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Helicobacter Pylori detection
- description
- Systematic biopsies of the tumor and the gastric cavity will be performed during the initial fibroscopy in accordance with the recommendations of the French Society of Digestive Endoscopy (SFED).
- interventionNames
- Biological: Helicobacter Pylori detection
Primary outcomes (1)
- measure
- Estimation of the prevalence of Helicobacter pylori
- timeFrame
- At baseline
- description
- Helicobacter Pylori has detected by immunohistochemistry in the stomach of patients with gastric cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer 2. Patient having read the information note and having signed the consent to participate in the study 3. Patient with social security coverage Exclusion Criteria: 1. Refusal to participate 2. Patient who could not answer the questionnaires 3. Patient not affiliated to a social security system 4. Patient not fluent in French 5. Patient under legal protection (legal protection, guardianship, curators, etc.)
References
Publications (0)
Data not yet available